
Spiro Gavaris
Spiro is responsible for the overall strategy, implementation, and growth of Lupin’s U.S. Generics Business.
Prior to joining Lupin, he gained comprehensive pharma, injectables and biotech experience, most notably serving as the President, Specialty Generics at Mallinckrodt Pharmaceuticals and President, US Injectables at Hikma.
Spiro holds a Bachelor’s degree from Franklin & Marshall College and MBA from New York University Stern School of Business.


Global Privacy Control Detected
We have detected your Global Privacy Control (GPC) signal. In accordance with applicable privacy laws, we have automatically honored your preference and disabled all non-essential cookies and tracking.
Only necessary cookies required for the website to function are enabled.
Opt-Out Request Honored
We have respected your privacy preference. Your opt-out request through cookie settings or Global Privacy Control signal has been honored.
